Meta-analyses showed both methadone and buprenorphine cut mortality risk in half compared to no treatment, marking a significant shift in Canadian guidelines that now recommend them as equal first-line options for opioid use disorder.
New data from 227,866 patients shows semaglutide associated with 36% reduced risk of alcohol-related hospitalizations versus traditional AUD medications' modest 2% reduction.
With violence rates reaching up to 87.5% globally, doctors face a 16 times higher risk of assault than other professionals—are safety measures keeping up in health care?
Adolescent cannabis users show increased psychosis symptoms even before use begins, underscoring shared vulnerabilities and self-medication factors in psychosis risk.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Psychosis patients face up to 2.6 times higher mortality risk after prison release, with overdose and suicide leading the causes—highlighting critical gaps in post-release care.
FTC finalizes rule requiring subscription-based businesses to provide cancellation processes as simple as enrollment methods, effective 180 days after Federal Register publication.